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 Therapeutics IV - Pharmacy 554  -  Spring 2014 
 
Course Coordinator: WJD   M, T  1310-1500     SB 114 
Instructors:     F 1510-1730 (Tests) 
wjd Bill Docktor  william.docktor@umontana.edu  5713 
dra Doug Allington douglas.allington@umontana.edu    2498 
kh Katherine Hale katherine.hale@umontana.edu  4647 
gac Gayle Hudgins gayle.hudgins@umontana.edu   6495 
 vjc Vince Colucci  vincent.colucci@umontana.edu   4634 
 sn Sarah Norman  sarah.norman@providence.org  520 784-8205  
 
Disabilities 
Students with disabilities may request reasonable modifications by contacting me.  The University of 
Montana assures equal access to instruction through collaboration between students with 
disabilities, instructors, and Disability Services for Students (DSS).  “Reasonable” means the 
University permits no fundamental alterations of academic standards or retroactive modifications.  
For more information, please consult http://www.umt.edu/disability.  If you think you may have a 
disability adversely affecting your academic performance, and you have not already registered with 
DSS, please contact DSS in Lommasson 154.   I will work with you and DSS to provide an 
appropriate accommodation. 
 
The University requires the following statement on all syllabi: 
“All students must practice academic honesty.  Academic misconduct is subject to an academic 
penalty by the course instructor and/or a disciplinary sanction by the University.  All students 
need to be familiar with the Student Conduct Code.  The Code is available for review online at 
http://life.umt.edu/vpsa/student_conduct.php 
 
 
Material and Resources 
Required Texts: DiPiro: Pharmacotherapy 
APhA: Handbook of Nonprescription Drugs 
Goodman & Gilman's Pharmacological Basis of Therapeutics  
Boh’s Pharmacy Practice Manual: A Guide to the Clinical Experience 
Susan Stein,   OR a diagnostic and laboratory book 
A medical dictionary 
Optional Texts: Clinical Pharmacokinetics Pocket Reference, John Murphy  
(strongly recommended) 
   Young, Koda-Kimble:  Applied Therapeutics 
Course Orientation 
Pharmacotherapy is drug therapy.  It involves the application of drug knowledge to the 
treatment of patients.  This requires organizational skills, critical thinking skills, problem solving 
skills, communication skills, and creativity as well as an understanding of drugs, diseases, and 
people.  This course will focus on the analytical, synthesizing, and evaluative skills needed to 
assess drug therapy and formulate and communicate a solution.  Although knowledge is not the 
primary focus, you will learn much information by using it to solve pharmacotherapeutic  
 2 
problems.     
  
Pharm. D. Program Outcomes addressed by this course:  IA, IB, III, VIA, VIB, VIIA, 
VIIIA,VIIIC  
 
These outcomes may be found on the program website (under “current students” then “documents”) but 
are reproduced for you below:  http://pharmacy.health.umt.edu/documents-and-links 
 
University of Montana - Doctor of Pharmacy Program Mission and Outcomes Statement (9-10-09) 
 
The mission of the Doctor of Pharmacy Program is to prepare future pharmacists, in both formal and 
informal learning environments, to provide patient-centered and population-based care and to manage the 
systems within which pharmacists work while fostering professionalism, leadership and advocacy, 
interprofessional collaboration, self-directed learning, cultural competency and scholarship. 
 
In achieving the mission of the Doctor of Pharmacy Program, graduates will have the ability* (knowledge, 
skills, attitudes and values) to: 
 
I. Provide patient-centered care 
A. Integrate and apply biomedical, pharmaceutical, social/behavioral/administrative, and clinical 
sciences 
B. Ensure optimal pharmacotherapy for patients 
 
II. Communicate effectively with patients, families, caregivers, and health care professionals 
 
III. Use critical thinking and problem solving skills to enhance patient care 
 
IV. Work effectively within an interprofessional team 
 
V. Manage and utilize resources of the health care system for the benefit of individual and public health. 
A. Promote patient and public safety 
B. Perform quality assurance techniques to improve the medication use system 
C.  Seek to reduce health care disparities. 
 
VI. Efficiently utilize information resources and technology 
A. Identify, retrieve and interpret relevant professional literature 
B. Communicate evidence-based information to other health care providers, patients, and the 
public 
 
VII. Promote public health 
A. Promote health improvement, wellness, and disease prevention 
B. Solve, or contribute to, solutions to public health problems 
 
VIII. Practice professionally 
A. Apply ethical, social, legal and economic principles to practice 
B. Respond to patients’ needs in a culturally sensitive manner 
C. Apply practice standards to optimize patient care 
D. Maintain professional competence by becoming a self-directed learner  
 
IX. Be a good citizen, demonstrate leadership and contribute to the community 
 
X. Engage in scholarly activity 
A. Use a scholarly approach to become an agent of change to advance pharmacy practice 
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B. Demonstrate a commitment to life-long learning 
 
*Each ability is many faceted.  The ACPE Accreditation Standards, Guidelines, and Appendices 
  (http://www.acpe-ccredit.org/pdf/ACPE_Revised_PharmD_Standards_Adopted_Jan152006.DOC) and 
  the CAPE Educational Outcomes 2004 and Supplements 
  (http://www.aacp.org/Docs/MainNavigation/Resources/6075_CAPE2004.pdf) 
  describe these abilities in much more detail and can be consulted for further definition. 
 
Goals of the Course 
 
To develop and utilize organizational skills, critical thinking skills, problem solving 
skills, and communications skills to benefit patients. 
 
To promote the students‟ understanding of pathophysiology of cardiovascular, 
psychiatric, and neurological disorders with particular emphasis on the facets of diseases 
that are amenable to drug therapy. 
 
To augment the student's understanding of the management of cardiovascular, psychiatric, 
and neurological disorders with particular emphasis on pharmacotherapy. 
 
To familiarize the student with the proper use of drugs in a clinical setting. 
 
To develop the student‟s awareness of factors that should be considered prior to selection 
of a drug and the appropriate parameters that should be monitored for therapeutic as well 
as undesired effects. 
 
Performance Objectives 
 
Upon completion of this course, each student shall be able to: 
 
Organize patient information into a problem list with supporting data. 
 
Relate the pathophysiology of a disease to the known or purported action(s) of a drug. 
 
Evaluate the seriousness of a disorder based on the signs and symptoms related to a 
diagnosed problem, and: 
--determine the necessity of drug therapy, 
--when applicable, choose the proper drug, dosage, and/or drug product for the 
situation.  
 
Determine the role of non-pharmacologic therapy. 
 
Tailor the drug therapy to an individual based on patient characteristics and 
pharmacokinetic and pharmacoeconomic principles. 
 
Monitor the appropriate parameters of a disease to determine if the patient is responding 
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positively to therapy. 
 
Monitor for adverse drug reactions and exacerbation of underlying patient problems 
resulting from drug therapy. 
 
Identify potential drug-drug interactions, and put forth an appropriate plan to mitigate 
these issues. 
 
Identify and formulate solutions for specific drug related problems 
 
Evaluate potential solutions for a given patient‟s drug related problem to optimize his/her 
pharmacotherapy.  
 
Communicate pharmacotherapeutic suggestions effectively. 
 
More Specific Goals and Objectives are attached to the handout for each topic. 
 
Student Responsibilities and Obligations 
 
To do assigned readings and studying from the texts before the corresponding class 
sessions. 
 
To attend and participate in class discussions. 
 
To perform clinical assessments and recommendations successfully on take-home cases 
and write professional consultations. 
 
 To perform satisfactorily on tests. 
 
Testing and Grading: 
Your grade is determined by your responses on take-home cases and tests.  Both take-homes and 
tests require you to utilize material that you were exposed to and should have learned in prior 
classes.  Take-home cases should be evaluated to identify any drug related problem and propose 
solutions to these problems.  The rationale for your recommendation is an essential component 
and should be stated completely.  The “why” is more important than the “what”.  More specific 
information for what is needed in the answer is provided in the rubric for each case. 
 
Unless other arrangements have been made with the course coordinator (wjd) prior to the due 
date, these assignments must be turned in on time if credit is to be awarded.  Discussion of 
these take-home assignments among students is encouraged.  However, each student must write 
their own answers. No other student should ever see your written response; this will be 
considered academic dishonesty.  Identical, or virtually identical, responses will be considered 
academic dishonesty and lead to failure of the course.  .            
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Pharmacokinetics topics will be graded in two ways:  test questions and take-home cases.  The 
homework should include: 
-an evaluation of the patient and current dosage of the drug, 
-calculations (if needed) including (at a minimum) formulae, numbers substituted in, and the 
answer, and 
-a written consultation to the physician with your evaluation, recommendations, and justification. 
 
The test questions are usually:  1)  evaluate this persons therapy and state if you agree or 
disagree.  If you agree, state why.  If you disagree, state why, suggest an alternative, and justify 
your choice, or 2)  Critique this prescription.  If you agree, state why.  If you disagree, state why, 
suggest an alternative, and justify your choice.    
 
There will be four tests, two cardiac, one psychiatric, and one neurologic.  These will be open 
book and open notebook.  No electronic devices are allowed.  Questions will be case scenarios, 
similar to take-home cases.  You will need to organize data, evaluate, recognize problems, and 
generate, justify and communicate solutions. 
 
Academic dishonesty, also known as cheating, will not be tolerated in any form.  Academic 
dishonesty will result in failure of the course. One form of academic dishonesty is plagiarism. 
According to the Online Writing Lab of Purdue University, last updated on March 27, 2013 by 
Karl Stolley, Allen Brizee, Joshua M. Paiz, plagiarism “is the uncredited use (both intentional 
and unintentional) of somebody else's words or ideas.”  As for the definition of plagiarism as 
defined on the website www.plagiarism.org (2013) “All of the following are considered 
plagiarism: 
turning in someone else's work as your own 
copying words or ideas from someone else without giving credit 
failing to put a quotation in quotation marks 
giving incorrect information about the source of a quotation 
changing words but copying the sentence structure of a source without giving credit 
copying so many words or ideas from a source that it makes up the majority of your work, 
whether you give credit or not (see our section on "fair use" rules)” 
 
Grading: Your grade in Therapeutics IV is based on total points.  A point is a point, whether it is 
on a test or on a homework assignment.  Grades are based on the original curve (see below);  
NOT  the 90/80/70/60 to which you have become accustomed..   At the end of the course, I will 
put the total points in a distribution and  look for natural breaks to divide between grades.  A, B, 
C, D, or F are the only possibilities, there are no +/-„s.    
There are a few guarantees.  
1. All assignments must be completed or you will fail the course no matter how 
many points you have accumulated. 
2. You are guaranteed, at least  a(n): 
  A if you achieve > 93% of the highest grade 
  B if you achieve > 86% of the highest grade 
  C if you achieve  > 79% of the highest grade 
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  D if you achieve > 72% of  the highest grade. 
I calculate this percentage on the basis of the highest grade achieved in the class.  I figure the rest 
are our fault.  Therefore, the percentage on any given assignment is irrelevant.  These cuts are not 
absolute.  They will never go up.  They often go down, based on gaps between groups of 
students.    
  
An assessment schedule is attached.  Grades are presented and kept on Moodle.  This is not 
intended to be an online course.  If faculty want to post materials they can, but not all course 
materials will be available online.   
 
 
Syllabus: 
Reading and studying are REQUIRED.  The contents of the assigned pages, some of which may 
not be discussed in class, will be included on cases and tests.  You are expected to have read and 
STUDIED each chapter and be ready to discuss it before the assigned class time.  In addition, 
you are expected to bring what you have learned in previous classes, such as pharmacokinetics, 
pharmacology, pharmaceutics, and therapeutics.  
 
Chapter is chapter of DiPiro, eighth edition) as a Study Assignment to be done before class  
Day Month Date Topic Instructor Chapter 
M Jan 27 Introduction 
Ischemic Heart Disease 
wjd 
vjc 
 
23 
T Jan 28 Ischemic Heart Disease vjc 24 
M Feb 03 Electrocardiograms 
Dysrhythmias 
vjc 17 
18 
T  04 Dysrhythmias vjc 25 
M  10 Dysrhythmias vjc  
T  11 Digoxin Pharmacokinetic – bring 
calculators 
wjd 8 
M  17 Presidents‟ Holiday   
T  18 Hypertension  kh 19, JNC-8 
F  21 Test One  thru Dig PK  1510-1740 SB114/117  
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M  24 Hypertension 
Lipid 
kh 28 
2013 
ACC/AHA 
Guideli
ne on 
the 
Treatme
nt of 
Blood 
Cholest
erol to 
Reduce 
ASCVD 
Risk in 
Adults 
T Feb 25 Lipid kh  
M Mar 03 Alcohol withdrawal 
Heart Failure 
wjd 
vjc 
 
20, 21 
T  04 Heart Failure vjc 22 
M  10 Hemodynamics vjc  
T  11 Shock vjc 30, 31 
M  17 Schizophrenia sn 76 
T  18 Schizophrenia 
Depression 
sn 
 
 
77 
F  21 Test two HTN thru Shock  1510-1740 SB114/117  
M  24 Depression 
Bipolar Disorder 
sn  
78 
T  25 Bipolar Disorder 
Anxiety Disorders 
sn 
wjd 
 
79 
M Mar 31 Spring    
T Apr 01 Break   
M  07 Anxiety Disorders wjd 80 
T  08 Sleep Disorders wjd 81 
M  14 ADHD wjd 72 
T  15 ADHD 
Anticonvulsant Pharmacokinetics 
 
dra 
 
 
F  18 Test three   schiz thru sleep 1510-1740 SB114/117  
M  21 Anticonvulsant Pharmacokinetics 
Seizures 
dra 65 
T  22 Seizures dra 66 
M  28 Parkinson‟s disease  68 
T Apr 29 Dementia gah 63 
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M May 05 Multiple Sclerosis 
Spinal Cord Injury 
dra 64 
T  06 in lieu of tests   
M  12 Test 4 ADHD thru SCI   1310-1540 S SB169  
 
Assessment Schedule   (*due during break week or a holiday, so plan for it) 
 
Instructor Points Assessment Due Student Due to 
Instructor 
vjc 15 Ischemic Heart Disease 1/28 2/4 
vjc 30 Dysrhythmias 2/10 2/17 
wjd 10 Digoxin Pharmacokinetics 2/11 2/18 
 55    
kh 15 Hypertension  2/24 3/3 
kh 15 Lipids 2/25 3/4 
 55 Test One  1510-1730 thru 
Dig PK    SB114/117 
2/21 2/21 
wjd 5 Alcohol withdrawal 3/3 3/10 
vjc 15 Heart Failure 3/4 3/11 
vjc 10 Hemodynamics 3/10 3/17 
en 10 Shock 3/11 3/18 
 70 Test two HTN thru Shock  
1510-1740 
3/21 3/21 
wjd 15 Schizophrenia 3/18 3/25 
wjd 10 Depression 3/24 3/31* 
wjd 10 Bipolar Disorder 3/25 4/1* 
wjd 15 Anxiety 4/7 4/14 
wjd 10 Sleep Disorders 4/8 4/15 
 60 Test three  Schiz thru sleep 
1310-1530 
SB 114/117 
4/18 4/18 
wjd 15 ADHD 4/15 4/22 
dra 10 Anticonvulsant 
Pharmacokinetics 
4/21 4/28 
dra 15 Seizure Disorders 4/22 4/29 
dra 10 Parkinson‟s 4/28 5/5 
gah 10 Dementia 4/29 5/6 
dra 5 Multiple Sclerosis 5/6 5/13 
dra 5 Spinal Cord Injury 5/6 5/13 
 70 Test Four ADHD thru SCI  
1310-1540       SB169 
5/14 5/14 
 
